Hypofractionated Spot Scanning Proton Therapy for Head and Neck Mucosal Melanoma: A Retrospective Analysis With Quality‐of‐Life Outcome
Head & Neck · 2025
DOI: 10.1002/hed.70121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, 2025. Verfasst von Koichiro Nakajima und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Nagoya Proton Therapy Center, Nagoya City University West Medical Center, Nagoya, Japan. Hauptthemen laut MEDLINE: Quality of Life, Melanoma, Proton Therapy, Head and Neck Neoplasms. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Objective
To evaluate clinical outcomes and quality of life (QOL) following hypofractionated spot‐scanning proton therapy (SSPT) for head and neck malignant mucosal melanoma (HNMM).
Methods
This retrospective study included 39 patients treated with SSPT (60–64 Gy[RBE] in 15–16 fractions) between 2013 and 2023. Endpoints included overall survival (OS), local control (LC), progression‐free survival (PFS), toxicities, and QOL.
Results
Most tumors were located in the sinonasal cavity ( n = 32). Surgery was performed in 8 patients; 19 received immune checkpoint inhibitors post‐SSPT. The 3‐year OS, LC, and PFS were 50%, 83%, and 30%, respectively. Larger tumor volumes (≥ 20 cm 3 ) were linked to worse PFS. Grade 3 mucositis occurred in 13%. Late toxicities included sinus disorder, osteonecrosis, and blindness (3%–5%). QOL was largely preserved, with notable declines in pain, swallowing, and mouth opening.
Conclusion
SSPT provides favorable LC with acceptable toxicity. Effective systemic therapies are needed to improve long‐term outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Nagoya Proton Therapy Center, Nagoya City University West Medical Center, Nagoya, Japan.
- Department of Otorhinolaryngology, Nagoya City University West Medical Center, Nagoya, Japan.
- Department of Oral and Maxillofacial Surgery, Nagoya City University West Medical Center, Nagoya, Japan.
- Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
- Department of Proton Therapy Technology, Nagoya Proton Therapy Center, Nagoya City West Medical Center, Nagoya, Japan.
- Department of Proton Therapy Physics, Nagoya Proton Therapy Center, Nagoya City West Medical Center, Nagoya, Japan.
ORCID-Profile: Koichiro Nakajima, Hiromitsu Iwata, Yusuke Tsuzuki
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Nakajima, K., Iwata, H., Takano, G., Kojima, D., Hattori, Y., Tsuzuki, Y., Sudo, S., Hayashi, K., Toshito, T., Fukano, H., Ogino, H., & Hiwatashi, A. (2025). Hypofractionated Spot Scanning Proton Therapy for Head and Neck Mucosal Melanoma: A Retrospective Analysis With Quality‐of‐Life Outcome. Head & Neck. https://doi.org/10.1002/hed.70121
Vancouver
Nakajima K, Iwata H, Takano G, Kojima D, Hattori Y, Tsuzuki Y, et al. Hypofractionated Spot Scanning Proton Therapy for Head and Neck Mucosal Melanoma: A Retrospective Analysis With Quality‐of‐Life Outcome. Head & Neck. 2025. doi:10.1002/hed.70121
BibTeX
@article{Nakajima2025,
author = {Nakajima, Koichiro and Iwata, Hiromitsu and Takano, Gaku and Kojima, Daiki and Hattori, Yukiko and Tsuzuki, Yusuke and Sudo, Shuou and Hayashi, Kensuke and Toshito, Toshiyuki and Fukano, Hideo and Ogino, Hiroyuki and Hiwatashi, Akio},
title = {Hypofractionated Spot Scanning Proton Therapy for Head and Neck Mucosal Melanoma: A Retrospective Analysis With Quality‐of‐Life Outcome},
journal = {Head & Neck},
year = {2025},
doi = {10.1002/hed.70121}
}
EUVIMED